252 related articles for article (PubMed ID: 38189294)
1. Role of intestinal flora in the development of nonalcoholic fatty liver disease in children.
Zhang J; Shi M; Zhao C; Liang G; Li C; Ge X; Pei C; Kong Y; Li D; Yang W; Cao B; Fu L; Yan Y; Wu J; Zhou J; Fang Y; Meng X; Li Y; Wang L
Microbiol Spectr; 2024 Feb; 12(2):e0100623. PubMed ID: 38189294
[TBL] [Abstract][Full Text] [Related]
2. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
Schwimmer JB; Johnson JS; Angeles JE; Behling C; Belt PH; Borecki I; Bross C; Durelle J; Goyal NP; Hamilton G; Holtz ML; Lavine JE; Mitreva M; Newton KP; Pan A; Simpson PM; Sirlin CB; Sodergren E; Tyagi R; Yates KP; Weinstock GM; Salzman NH
Gastroenterology; 2019 Oct; 157(4):1109-1122. PubMed ID: 31255652
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan.
Tsai MC; Liu YY; Lin CC; Wang CC; Wu YJ; Yong CC; Chen KD; Chuah SK; Yao CC; Huang PY; Chen CH; Hu TH; Chen CL
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32204538
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice.
Zhuge A; Li S; Lou P; Wu W; Wang K; Yuan Y; Xia J; Li B; Li L
Microbiol Spectr; 2022 Jun; 10(3):e0004722. PubMed ID: 35647690
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiota, Glucose, Lipid, and Water-Electrolyte Metabolism in Children With Nonalcoholic Fatty Liver Disease.
Pan X; Kaminga AC; Liu A; Wen SW; Luo M; Luo J
Front Cell Infect Microbiol; 2021; 11():683743. PubMed ID: 34778099
[TBL] [Abstract][Full Text] [Related]
6. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
[TBL] [Abstract][Full Text] [Related]
7. Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Abdollahiyan S; Nabavi-Rad A; Keshavarz Azizi Raftar S; Monnoye M; Salarieh N; Farahanie A; Asadzadeh Aghdaei H; Zali MR; Hatami B; Gérard P; Yadegar A
Sci Rep; 2023 Nov; 13(1):20584. PubMed ID: 37996480
[TBL] [Abstract][Full Text] [Related]
8. Integrative metabolomics highlights gut microbiota metabolites as novel NAFLD-related candidate biomarkers in children.
Luo J; Luo M; Kaminga AC; Wei J; Dai W; Peng Y; Zhao K; Duan Y; Xiao X; Ouyang S; Yao Z; Liu Y; Pan X
Microbiol Spectr; 2024 Apr; 12(4):e0523022. PubMed ID: 38445874
[TBL] [Abstract][Full Text] [Related]
9. Metagenomic identification of gut microbiota distribution on the colonic mucosal biopsy samples in patients with non-alcoholic fatty liver disease.
Delik A; Dinçer S; Ülger Y; Akkız H; Karaoğullarından Ü
Gene; 2022 Jul; 833():146587. PubMed ID: 35598686
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach.
Del Chierico F; Nobili V; Vernocchi P; Russo A; De Stefanis C; Gnani D; Furlanello C; Zandonà A; Paci P; Capuani G; Dallapiccola B; Miccheli A; Alisi A; Putignani L
Hepatology; 2017 Feb; 65(2):451-464. PubMed ID: 27028797
[TBL] [Abstract][Full Text] [Related]
11. Interplay of Lymphocytes with the Intestinal Microbiota in Children with Nonalcoholic Fatty Liver Disease.
Liang T; Li D; Zunong J; Li M; Amaerjiang N; Xiao H; Khattab NM; Vermund SH; Hu Y
Nutrients; 2022 Nov; 14(21):. PubMed ID: 36364902
[TBL] [Abstract][Full Text] [Related]
12.
Tian G; Wang W; Xia E; Chen W; Zhang S
Front Cell Infect Microbiol; 2023; 13():1078447. PubMed ID: 36860985
[TBL] [Abstract][Full Text] [Related]
13. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.
Boursier J; Mueller O; Barret M; Machado M; Fizanne L; Araujo-Perez F; Guy CD; Seed PC; Rawls JF; David LA; Hunault G; Oberti F; Calès P; Diehl AM
Hepatology; 2016 Mar; 63(3):764-75. PubMed ID: 26600078
[TBL] [Abstract][Full Text] [Related]
14. From gut to liver: unveiling the differences of intestinal microbiota in NAFL and NASH patients.
Huang F; Lyu B; Xie F; Li F; Xing Y; Han Z; Lai J; Ma J; Zou Y; Zeng H; Xu Z; Gao P; Luo Y; Bolund L; Tong G; Fengping X
Front Microbiol; 2024; 15():1366744. PubMed ID: 38638907
[TBL] [Abstract][Full Text] [Related]
15. Disease-Associated Gut Microbiota Reduces the Profile of Secondary Bile Acids in Pediatric Nonalcoholic Fatty Liver Disease.
Yu J; Zhang H; Chen L; Ruan Y; Chen Y; Liu Q
Front Cell Infect Microbiol; 2021; 11():698852. PubMed ID: 34568090
[TBL] [Abstract][Full Text] [Related]
16. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
[TBL] [Abstract][Full Text] [Related]
17. The fecal mycobiome in non-alcoholic fatty liver disease.
Demir M; Lang S; Hartmann P; Duan Y; Martin A; Miyamoto Y; Bondareva M; Zhang X; Wang Y; Kasper P; Bang C; Roderburg C; Tacke F; Steffen HM; Goeser T; Kruglov A; Eckmann L; Stärkel P; Fouts DE; Schnabl B
J Hepatol; 2022 Apr; 76(4):788-799. PubMed ID: 34896404
[TBL] [Abstract][Full Text] [Related]
18. Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects.
Yun Y; Kim HN; Lee EJ; Ryu S; Chang Y; Shin H; Kim HL; Kim TH; Yoo K; Kim HY
PLoS One; 2019; 14(3):e0213692. PubMed ID: 30870486
[TBL] [Abstract][Full Text] [Related]
19. Tangshen formula targets the gut microbiota to treat non-alcoholic fatty liver disease in HFD mice: A 16S rRNA and non-targeted metabolomics analyses.
Wang S; Li X; Zhang B; Li Y; Chen K; Qi H; Gao M; Rong J; Liu L; Wan Y; Dong X; Yan M; Ma L; Li P; Zhao T
Biomed Pharmacother; 2024 Apr; 173():116405. PubMed ID: 38484559
[TBL] [Abstract][Full Text] [Related]
20. Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease.
Zhang Y; Xu J; Wang X; Ren X; Liu Y
BMC Genomics; 2019 Nov; 20(1):862. PubMed ID: 31726978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
